Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
5000 participants
OBSERVATIONAL
2019-05-20
2025-05-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Volunteers to Investigate Best Results for Ablation and Novel Therapies for Atrial Fibrillation
NCT05504356
International Registry on Cardioversion of Atrial Fibrillation (MK-6621-051)
NCT01119716
Atrial Fibrillation Registry 2017
NCT05023590
Atrial Fibrillation (AF) Ablation to Prevent Disease Progression of AF-induced Atrial Cardiomyopathy in Women and Men
NCT06200311
Low Fluoroscopy Afib Ablation Registry
NCT02830750
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
OTHER
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Atrial Fibrillation Ablation
A procedure used to treat an irregular heart rhythm (arrhythmia)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. 18 years and older
3. Undergoing percutaneous catheter ablation procedures to treat atrial fibrillation
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hoag Memorial Hospital Presbyterian
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Colleen Balius
Clinical Data Coordinator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Leila Andres
Role: STUDY_CHAIR
Hoag Memorial Hospital Presbyterian
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hoah Memorial Hospital Presbyterian
Newport Beach, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
171-19-CV
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.